文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

妇科恶性肿瘤的立体定向体部放疗:基于病例的放射外科协会实践综述

Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review.
PubMed 文献 · Pract Radiat Oncol · 2023-10-22

放射外科协会基于三个妇科恶性肿瘤病例(卵巢癌腹主动脉旁淋巴结寡复发、宫颈癌盆壁寡复发、不可手术子宫内膜癌盆腔调强放疗后推量)编写实践综述,讨论患者选择、分次方案、处方剂量、治疗技术与剂量限值,并总结相关文献。作者指出,常规分次放疗和近距离放疗仍是根治性治疗的标准,SBRT可能在姑息病例或高剂量因毒性不可接受而不需高剂量的病例中发挥作用。

要点

  • SBRT用于妇科恶性肿瘤仍存争议,需综合考虑治疗目的、患者选择、分次方案、肿瘤定位和计划优化。
  • 常规分次放疗和近距离放疗仍是妇科恶性肿瘤根治性治疗的标准。
  • SBRT可能在姑息病例或高剂量因毒性不可接受而不需高剂量的病例中发挥作用。

核心结论

  • 作者指出,常规分次放疗和近距离放疗仍是妇科恶性肿瘤根治性治疗的标准,SBRT可能在姑息病例或高剂量因毒性不可接受而不需高剂量的病例中发挥作用。

研究设计与样本

  • 放射外科协会基于病例的实践综述,纳入三个场景:卵巢癌腹主动脉旁淋巴结寡复发(姑息)、宫颈癌盆壁寡复发(姑息)、不可手术子宫内膜癌盆腔调强放疗后推量(根治性)。

主要发现

  • SBRT治疗妇科恶性肿瘤需考虑治疗目的、最佳患者选择、分次选择、肿瘤定位和计划优化。
  • 综述围绕患者特征、分次方案、处方剂量、治疗技术和剂量限值展开讨论,并总结相关文献为类似患者提供治疗框架。

临床怎么用

  • 作者认为,SBRT可能在姑息病例或高剂量因毒性不可接受而不需高剂量的病例中发挥作用。
  • 作者指出,常规分次放疗和近距离放疗仍是妇科恶性肿瘤根治性治疗的标准。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The use of stereotactic body radiation therapy (SBRT) for gynecologic malignancies is controversial. We discuss certain circumstances when highly precise SBRT may be a useful tool to consider in the management of selected patients. METHODS AND MATERIALS: Case selection included the following scenarios, the first 2 with palliative intent, para-aortic nodal oligorecurrence of ovarian cancer, pelvic sidewall oligorecurrence of cervical cancer, and inoperable endometrial cancer boost after intensity modulated radiation to the pelvis treated with curative intent. Patient characteristics, fractionation, prescription dose, treatment technique, and dose constraints were discussed. Relevant literature to these cases was summarized to provide a framework for treatment of similar patients. RESULTS: Treatment of gynecologic malignancies with SBRT requires many considerations, including treatment intent, optimal patient selection, fractionation selection, tumor localization, and plan optimization. Although other treatment paradigms including conventionally fractionated radiation therapy and brachytherapy remain the standard-of-care for definitive treatment of gynecologic malignancies, SBRT may have a role in palliative cases or those where high doses are not required due to the unacceptable toxicity that may occur with SBRT. CONCLUSIONS: A case-based practice review was developed by the Radiosurgery Society to provide a practical guide to the common scenarios noted above affecting patients with gynecologic malignancies.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ladbury C, Sueyoshi MH, Brovold NM, et al. Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review. Pract Radiat Oncol. 2023. PMID: 37875223. doi:10.1016/j.prro.2023.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。